<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-02-01" modified="2020-08-12" version="211">
<accession>P41180</accession>
<accession>Q13912</accession>
<accession>Q16108</accession>
<accession>Q16109</accession>
<accession>Q16110</accession>
<accession>Q16379</accession>
<accession>Q2M1T0</accession>
<accession>Q4PJ19</accession>
<name>CASR_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="73">Extracellular calcium-sensing receptor</fullName>
<shortName evidence="70 72">CaR</shortName>
<shortName>CaSR</shortName>
<shortName evidence="69">hCasR</shortName>
</recommendedName>
<alternativeName>
<fullName evidence="71">Parathyroid cell calcium-sensing receptor 1</fullName>
<shortName evidence="71">PCaR1</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="75">CASR</name>
<name type="synonym">GPRC2A</name>
<name type="synonym" evidence="71">PCAR1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="N. Engl. J. Med." volume="335" first="1115" last="1122">
<title>A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor.</title>
<authorList>
<person name="Pearce S.H.S."/>
<person name="Williamson C."/>
<person name="Kifor O."/>
<person name="Bai M."/>
<person name="Coulthard M.G."/>
<person name="Davies M."/>
<person name="Lewis-Barned N."/>
<person name="McCredie D."/>
<person name="Powell H."/>
<person name="Kendall-Taylor P."/>
<person name="Brown E.M."/>
<person name="Thakker R.V."/>
</authorList>
<dbReference type="PubMed" id="8813042"/>
<dbReference type="DOI" id="10.1056/nejm199610103351505"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS HYPOC1 LYS-118; LEU-128; MET-151; LYS-191 AND SER-612</scope>
<scope>CHARACTERIZATION OF VARIANTS HYPOC1 LEU-128; MET-151 AND LYS-191</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="12919" last="12925">
<title>Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs.</title>
<authorList>
<person name="Garrett J.E."/>
<person name="Capuano I.V."/>
<person name="Hammerland L.G."/>
<person name="Hung B.C."/>
<person name="Brown E.M."/>
<person name="Hebert S.C."/>
<person name="Nemeth E.F."/>
<person name="Fuller F."/>
</authorList>
<dbReference type="PubMed" id="7759551"/>
<dbReference type="DOI" id="10.1074/jbc.270.21.12919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>FUNCTION</scope>
<scope>VARIANT GLY-990</scope>
<source>
<tissue>Parathyroid</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1995" name="Biochem. Biophys. Res. Commun." volume="214" first="524" last="529">
<title>Molecular cloning of a putative Ca(2+)-sensing receptor cDNA from human kidney.</title>
<authorList>
<person name="Aida K."/>
<person name="Koishi S."/>
<person name="Tawata M."/>
<person name="Onaya T."/>
</authorList>
<dbReference type="PubMed" id="7677761"/>
<dbReference type="DOI" id="10.1006/bbrc.1995.2318"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1996" name="Endocrinology" volume="137" first="3842" last="3848">
<title>Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretion.</title>
<authorList>
<person name="Freichel M."/>
<person name="Zink-Lorenz A."/>
<person name="Holloschi A."/>
<person name="Hafner M."/>
<person name="Flockerzi V."/>
<person name="Raue F."/>
</authorList>
<dbReference type="PubMed" id="8756555"/>
<dbReference type="DOI" id="10.1210/endo.137.9.8756555"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS SER-986; GLY-990 AND GLN-1011</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1995" name="J. Clin. Endocrinol. Metab." volume="80" first="2594" last="2598">
<title>Familial hypocalciuric hypercalcemia associated with mutation in the human Ca(2+)-sensing receptor gene.</title>
<authorList>
<person name="Aida K."/>
<person name="Koishi S."/>
<person name="Inoue M."/>
<person name="Nakazato M."/>
<person name="Tawata M."/>
<person name="Onaya T."/>
</authorList>
<dbReference type="PubMed" id="7673400"/>
<dbReference type="DOI" id="10.1210/jcem.80.9.7673400"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-61</scope>
<scope>VARIANT HHC1 ALA-39</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="J. Clin. Invest." volume="97" first="1085" last="1093">
<title>Changes in calcium responsiveness and handling during keratinocyte differentiation. Potential role of the calcium receptor.</title>
<authorList>
<person name="Bikle D.D."/>
<person name="Ratnam A."/>
<person name="Mauro T."/>
<person name="Harris J."/>
<person name="Pillai S."/>
</authorList>
<dbReference type="PubMed" id="8613532"/>
<dbReference type="DOI" id="10.1172/jci118501"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 643-908</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="11610" last="11617">
<title>Calcium-sensing receptor ubiquitination and degradation mediated by the E3 ubiquitin ligase dorfin.</title>
<authorList>
<person name="Huang Y."/>
<person name="Niwa J."/>
<person name="Sobue G."/>
<person name="Breitwieser G.E."/>
</authorList>
<dbReference type="PubMed" id="16513638"/>
<dbReference type="DOI" id="10.1074/jbc.m513552200"/>
</citation>
<scope>INTERACTION WITH VCP AND RNF19A</scope>
<scope>GLYCOSYLATION</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="3759" last="3764">
<title>Structures of the extracellular regions of the group II/III metabotropic glutamate receptors.</title>
<authorList>
<person name="Muto T."/>
<person name="Tsuchiya D."/>
<person name="Morikawa K."/>
<person name="Jingami H."/>
</authorList>
<dbReference type="PubMed" id="17360426"/>
<dbReference type="DOI" id="10.1073/pnas.0611577104"/>
</citation>
<scope>DOMAIN</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2010" name="Endocrinology" volume="151" first="5114" last="5123">
<title>Rab1 small GTP-binding protein regulates cell surface trafficking of the human calcium-sensing receptor.</title>
<authorList>
<person name="Zhuang X."/>
<person name="Adipietro K.A."/>
<person name="Datta S."/>
<person name="Northup J.K."/>
<person name="Ray K."/>
</authorList>
<dbReference type="PubMed" id="20861236"/>
<dbReference type="DOI" id="10.1210/en.2010-0422"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2015" name="Mol. Pharmacol." volume="88" first="853" last="865">
<title>Critical cysteine residues in both the calcium-sensing receptor and the allosteric activator AMG 416 underlie the mechanism of action.</title>
<authorList>
<person name="Alexander S.T."/>
<person name="Hunter T."/>
<person name="Walter S."/>
<person name="Dong J."/>
<person name="Maclean D."/>
<person name="Baruch A."/>
<person name="Subramanian R."/>
<person name="Tomlinson J."/>
</authorList>
<dbReference type="PubMed" id="26290606"/>
<dbReference type="DOI" id="10.1124/mol.115.098392"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
<scope>MUTAGENESIS OF CYS-482</scope>
</reference>
<reference key="13" evidence="3 4">
<citation type="journal article" date="2016" name="Elife" volume="5">
<title>Structural mechanism of ligand activation in human calcium-sensing receptor.</title>
<authorList>
<person name="Geng Y."/>
<person name="Mosyak L."/>
<person name="Kurinov I."/>
<person name="Zuo H."/>
<person name="Sturchler E."/>
<person name="Cheng T.C."/>
<person name="Subramanyam P."/>
<person name="Brown A.P."/>
<person name="Brennan S.C."/>
<person name="Mun H.C."/>
<person name="Bush M."/>
<person name="Chen Y."/>
<person name="Nguyen T.X."/>
<person name="Cao B."/>
<person name="Chang D.D."/>
<person name="Quick M."/>
<person name="Conigrave A.D."/>
<person name="Colecraft H.M."/>
<person name="McDonald P."/>
<person name="Fan Q.R."/>
</authorList>
<dbReference type="PubMed" id="27434672"/>
<dbReference type="DOI" id="10.7554/elife.13662"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 20-607 IN COMPLEX WITH CALCIUM; ANION AND TRYPTOPHAN</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>DOMAIN</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-261; ASN-287; ASN-446; ASN-468; ASN-488; ASN-541 AND ASN-594</scope>
<scope>MUTAGENESIS OF ARG-69; ASN-102; THR-145; SER-147; SER-170; TYR-218; SER-417 AND TRP-458</scope>
<scope>CHARACTERIZATION OF VARIANTS NSHPT ILE-100; LEU-227 AND LYS-551</scope>
<scope>CHARACTERIZATION OF VARIANTS HHC1 HIS-66; MET-81; PRO-159; GLY-172; GLY-215; LYS-297 AND GLU-557</scope>
</reference>
<reference key="14" evidence="1 2">
<citation type="journal article" date="2016" name="Sci. Adv." volume="2" first="E1600241" last="E1600241">
<title>Structural basis for regulation of human calcium-sensing receptor by magnesium ions and an unexpected tryptophan derivative co-agonist.</title>
<authorList>
<person name="Zhang C."/>
<person name="Zhang T."/>
<person name="Zou J."/>
<person name="Miller C.L."/>
<person name="Gorkhali R."/>
<person name="Yang J.Y."/>
<person name="Schilmiller A."/>
<person name="Wang S."/>
<person name="Huang K."/>
<person name="Brown E.M."/>
<person name="Moremen K.W."/>
<person name="Hu J."/>
<person name="Yang J.J."/>
</authorList>
<dbReference type="PubMed" id="27386547"/>
<dbReference type="DOI" id="10.1126/sciadv.1600241"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 20-541 IN COMPLEX WITH MAGNESIUM AND TRYPTOPHAN</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>DOMAIN</scope>
<scope>DISULFIDE BONDS</scope>
<scope>MUTAGENESIS OF GLU-297</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1993" name="Cell" volume="75" first="1297" last="1303">
<title>Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.</title>
<authorList>
<person name="Pollak M.R."/>
<person name="Brown E.M."/>
<person name="Chou Y.-H.W."/>
<person name="Hebert S.C."/>
<person name="Marx S.J."/>
<person name="Steinmann B."/>
<person name="Levi T."/>
<person name="Seidman C.E."/>
<person name="Seidman J.G."/>
</authorList>
<dbReference type="PubMed" id="7916660"/>
<dbReference type="DOI" id="10.1016/0092-8674(93)90617-y"/>
</citation>
<scope>VARIANTS HHC1 GLN-185; LYS-297 AND TRP-795</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1994" name="Nat. Genet." volume="8" first="303" last="307">
<title>Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation.</title>
<authorList>
<person name="Pollak M.R."/>
<person name="Brown E.M."/>
<person name="Estep H.L."/>
<person name="McLaine P.N."/>
<person name="Kifor O."/>
<person name="Park J."/>
<person name="Hebert S.C."/>
<person name="Seidman C.E."/>
<person name="Seidman J.G."/>
</authorList>
<dbReference type="PubMed" id="7874174"/>
<dbReference type="DOI" id="10.1038/ng1194-303"/>
</citation>
<scope>VARIANT HYPOC1 ALA-127</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1995" name="Am. J. Hum. Genet." volume="56" first="1075" last="1079">
<title>Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia.</title>
<authorList>
<person name="Chou Y.-H.W."/>
<person name="Pollak M.R."/>
<person name="Brandi M.L."/>
<person name="Toss G."/>
<person name="Arnqvist H."/>
<person name="Atkinson A.B."/>
<person name="Papapoulos S.E."/>
<person name="Marx S."/>
<person name="Brown E.M."/>
<person name="Seidman J.G."/>
<person name="Seidman C.E."/>
</authorList>
<dbReference type="PubMed" id="7726161"/>
</citation>
<scope>VARIANTS HHC1 MET-62; CYS-66; MET-138; GLU-143 AND GLN-227</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1995" name="J. Clin. Invest." volume="96" first="2683" last="2692">
<title>Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.</title>
<authorList>
<person name="Pearce S.H.S."/>
<person name="Trump D."/>
<person name="Wooding C."/>
<person name="Besser G.M."/>
<person name="Chew S.L."/>
<person name="Grant D.B."/>
<person name="Heath D.A."/>
<person name="Hughes I.A."/>
<person name="Paterson C.R."/>
<person name="Whyte M.P."/>
<person name="Thakker R.V."/>
</authorList>
<dbReference type="PubMed" id="8675635"/>
<dbReference type="DOI" id="10.1172/jci118335"/>
</citation>
<scope>VARIANTS NSHPT LEU-227 AND TYR-582</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1996" name="Hum. Genet." volume="98" first="129" last="133">
<title>The Ca(2+)-sensing receptor gene (PCAR1) mutation T151M in isolated autosomal dominant hypoparathyroidism.</title>
<authorList>
<person name="Lovlie R."/>
<person name="Eiken H.G."/>
<person name="Sorheim J.I."/>
<person name="Boman H."/>
</authorList>
<dbReference type="PubMed" id="8698326"/>
<dbReference type="DOI" id="10.1007/s004390050174"/>
</citation>
<scope>VARIANT FIH MET-151</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1996" name="Hum. Mol. Genet." volume="5" first="601" last="606">
<title>Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism.</title>
<authorList>
<person name="Baron J."/>
<person name="Winer K.K."/>
<person name="Yanovski J.A."/>
<person name="Cunningham A.W."/>
<person name="Laue L."/>
<person name="Zimmerman D."/>
<person name="Cutler G.B. Jr."/>
</authorList>
<dbReference type="PubMed" id="8733126"/>
<dbReference type="DOI" id="10.1093/hmg/5.5.601"/>
</citation>
<scope>VARIANTS HYPOC1 THR-116; HIS-681 AND SER-806</scope>
<scope>VARIANT SER-851</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="19537" last="19545">
<title>Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor.</title>
<authorList>
<person name="Bai M."/>
<person name="Quinn S."/>
<person name="Trivedi S."/>
<person name="Kifor O."/>
<person name="Pearce S.H.S."/>
<person name="Pollak M.R."/>
<person name="Krapcho K."/>
<person name="Hebert S.C."/>
<person name="Brown E.M."/>
</authorList>
<dbReference type="PubMed" id="8702647"/>
<dbReference type="DOI" id="10.1074/jbc.271.32.19537"/>
</citation>
<scope>VARIANTS HHC1 MET-62; CYS-66; MET-138; GLU-143; GLN-185; LYS-297 AND TRP-795</scope>
<scope>VARIANT HYPOC1 ALA-127</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>GLYCOSYLATION</scope>
<scope>CHARACTERIZATION OF VARIANTS HHC1 MET-62; CYS-66; MET-138; GLU-143; GLN-185; LYS-297 AND TRP-795</scope>
<scope>CHARACTERIZATION OF VARIANT HYPOC1 ALA-127</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1996" name="J. Clin. Endocrinol. Metab." volume="81" first="1312" last="1317">
<title>Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains.</title>
<authorList>
<person name="Heath H. III"/>
<person name="Odelberg S."/>
<person name="Jackson C.E."/>
<person name="Teh B.T."/>
<person name="Hayward N."/>
<person name="Larsson C."/>
<person name="Buist N.R."/>
<person name="Krapcho K.J."/>
<person name="Hung B.C."/>
<person name="Capuano I.V."/>
<person name="Garrett J.E."/>
<person name="Leppert M.F."/>
</authorList>
<dbReference type="PubMed" id="8636323"/>
<dbReference type="DOI" id="10.1210/jcem.81.4.8636323"/>
</citation>
<scope>VARIANTS HHC1 PRO-53; LEU-55; GLN-185; GLY-215; TYR-657 AND ARG-748</scope>
<scope>VARIANTS SER-986; GLY-990 AND GLN-1011</scope>
<scope>CHARACTERIZATION OF VARIANTS HHC1 PRO-53; LEU-55 AND GLY-215</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1996" name="J. Clin. Invest." volume="98" first="1860" last="1866">
<title>Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells.</title>
<authorList>
<person name="Pearce S.H.S."/>
<person name="Bai M."/>
<person name="Quinn S.J."/>
<person name="Kifor O."/>
<person name="Brown E.M."/>
<person name="Thakker R.V."/>
</authorList>
<dbReference type="PubMed" id="8878438"/>
<dbReference type="DOI" id="10.1172/jci118987"/>
</citation>
<scope>VARIANTS HHC1 LEU-55; ASP-178; SER-221 AND ILE-817</scope>
<scope>VARIANTS HYPOC1 LEU-128; MET-151 AND LYS-191</scope>
<scope>VARIANT NSHPT LEU-227</scope>
<scope>CHARACTERIZATION OF VARIANTS HHC1 LEU-55; ASP-178; SER-221 AND ILE-817</scope>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANTS HYPOC1 LEU-128; MET-151 AND LYS-191</scope>
<scope>CHARACTERIZATION OF VARIANT NSHPT LEU-227</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1997" name="Hum. Mutat." volume="10" first="233" last="235">
<title>A novel mutation (L174R) in the Ca2+-sensing receptor gene associated with familial hypocalciuric hypercalcemia.</title>
<authorList>
<person name="Ward B.K."/>
<person name="Stuckey B.G.A."/>
<person name="Gutteridge D.H."/>
<person name="Laing N.G."/>
<person name="Pullan P.T."/>
<person name="Ratajczak T."/>
</authorList>
<dbReference type="PubMed" id="9298824"/>
<dbReference type="DOI" id="10.1002/(sici)1098-1004(1997)10:3&lt;233::aid-humu9&gt;3.0.co;2-j"/>
</citation>
<scope>VARIANT HHC1 ARG-174</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1997" name="J. Clin. Endocrinol. Metab." volume="82" first="2710" last="2715">
<title>Sporadic hypoparathyroidism caused by de Novo gain-of-function mutations of the Ca(2+)-sensing receptor.</title>
<authorList>
<person name="De Luca F."/>
<person name="Ray K."/>
<person name="Mancilla E.E."/>
<person name="Fan G.-F."/>
<person name="Winer K.K."/>
<person name="Gore P."/>
<person name="Spiegel A.M."/>
<person name="Baron J."/>
</authorList>
<dbReference type="PubMed" id="9253358"/>
<dbReference type="DOI" id="10.1210/jcem.82.8.4166"/>
</citation>
<scope>VARIANTS HYPOC1 LYS-118; ARG-773 AND SER-806</scope>
<scope>CHARACTERIZATION OF VARIANTS HYPOC1 LYS-118; ARG-773 AND SER-806</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1997" name="J. Clin. Endocrinol. Metab." volume="82" first="2716" last="2719">
<title>Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism.</title>
<authorList>
<person name="Kobayashi M."/>
<person name="Tanaka H."/>
<person name="Tsuzuki K."/>
<person name="Tsuyuki M."/>
<person name="Igaki H."/>
<person name="Ichinose Y."/>
<person name="Aya K."/>
<person name="Nishioka N."/>
<person name="Seino Y."/>
</authorList>
<dbReference type="PubMed" id="9253359"/>
<dbReference type="DOI" id="10.1210/jcem.82.8.4135"/>
</citation>
<scope>VARIANT NSHPT GLU-670</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1998" name="J. Clin. Endocrinol. Metab." volume="83" first="2497" last="2502">
<title>Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor.</title>
<authorList>
<person name="Watanabe T."/>
<person name="Bai M."/>
<person name="Lane C.R."/>
<person name="Matsumoto S."/>
<person name="Minamitani K."/>
<person name="Minagawa M."/>
<person name="Niimi H."/>
<person name="Brown E.M."/>
<person name="Yasuda T."/>
</authorList>
<dbReference type="PubMed" id="9661634"/>
<dbReference type="DOI" id="10.1210/jcem.83.7.4920"/>
</citation>
<scope>VARIANT HYPOC1 CYS-788</scope>
<scope>CHARACTERIZATION OF VARIANT HYPOC1 CYS-788</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1999" name="Clin. Endocrinol. (Oxf.)" volume="50" first="537" last="543">
<title>An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homozygous inactivating mutation of calcium-sensing receptor.</title>
<authorList>
<person name="Chikatsu N."/>
<person name="Fukumoto S."/>
<person name="Suzawa M."/>
<person name="Tanaka Y."/>
<person name="Takeuchi Y."/>
<person name="Takeda S."/>
<person name="Tamura Y."/>
<person name="Matsumoto T."/>
<person name="Fujita T."/>
</authorList>
<dbReference type="PubMed" id="10468915"/>
<dbReference type="DOI" id="10.1046/j.1365-2265.1999.00729.x"/>
</citation>
<scope>VARIANT ARG-27</scope>
<scope>CHARACTERIZATION OF VARIANT ARG-27</scope>
<scope>INVOLVEMENT IN PRIMARY HYPERPARATHYROIDISM</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1999" name="J. Clin. Endocrinol. Metab." volume="84" first="363" last="366">
<title>A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia.</title>
<authorList>
<person name="Okazaki R."/>
<person name="Chikatsu N."/>
<person name="Nakatsu M."/>
<person name="Takeuchi Y."/>
<person name="Ajima M."/>
<person name="Miki J."/>
<person name="Fujita T."/>
<person name="Arai M."/>
<person name="Totsuka Y."/>
<person name="Tanaka K."/>
<person name="Fukumoto S."/>
</authorList>
<dbReference type="PubMed" id="9920108"/>
<dbReference type="DOI" id="10.1210/jcem.84.1.5385"/>
</citation>
<scope>VARIANT HYPOC1 ASN-47</scope>
<scope>CHARACTERIZATION OF VARIANT HYPOC1 ASN-47</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1999" name="J. Clin. Endocrinol. Metab." volume="84" first="3036" last="3040">
<title>Autosomal dominant hypoparathyroidism associated with short stature and premature osteoarthritis.</title>
<authorList>
<person name="Stock J.L."/>
<person name="Brown R.S."/>
<person name="Baron J."/>
<person name="Coderre J.A."/>
<person name="Mancilla E."/>
<person name="De Luca F."/>
<person name="Ray K."/>
<person name="Mericq M.V."/>
</authorList>
<dbReference type="PubMed" id="10487661"/>
<dbReference type="DOI" id="10.1210/jcem.84.9.5977"/>
</citation>
<scope>VARIANT HYPOC1 VAL-616</scope>
<scope>CHARACTERIZATION OF VARIANT HYPOC1 VAL-616</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1999" name="Lancet" volume="353" first="112" last="115">
<title>A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations.</title>
<authorList>
<person name="Cole D.E.C."/>
<person name="Peltekova V.D."/>
<person name="Rubin L.A."/>
<person name="Hawker G.A."/>
<person name="Vieth R."/>
<person name="Liew C.C."/>
<person name="Hwang D.M."/>
<person name="Evrovski J."/>
<person name="Hendy G.N."/>
</authorList>
<dbReference type="PubMed" id="10023897"/>
<dbReference type="DOI" id="10.1016/s0140-6736(98)06434-4"/>
</citation>
<scope>VARIANT SER-986</scope>
<scope>ASSOCIATION WITH SERUM LEVEL OF CALCIUM</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2000" name="J. Clin. Endocrinol. Metab." volume="85" first="2042" last="2047">
<title>Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor.</title>
<authorList>
<person name="Carling T."/>
<person name="Szabo E."/>
<person name="Bai M."/>
<person name="Ridefelt P."/>
<person name="Westin G."/>
<person name="Gustavsson P."/>
<person name="Trivedi S."/>
<person name="Hellman P."/>
<person name="Brown E.M."/>
<person name="Dahl N."/>
<person name="Rastad J."/>
</authorList>
<dbReference type="PubMed" id="10843194"/>
<dbReference type="DOI" id="10.1210/jcem.85.5.6477"/>
</citation>
<scope>VARIANT HYPERCALCIURIC HYPERCALCEMIA LEU-881</scope>
<scope>CHARACTERIZATION OF VARIANT HYPERCALCIURIC HYPERCALCEMIA LEU-881</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2001" name="Endocrine" volume="15" first="277" last="282">
<title>A novel mutation in Ca2+-sensing receptor gene in familial hypocalciuric hypercalcemia.</title>
<authorList>
<person name="Nakayama T."/>
<person name="Minato M."/>
<person name="Nakagawa M."/>
<person name="Soma M."/>
<person name="Tobe H."/>
<person name="Aoi N."/>
<person name="Kosuge K."/>
<person name="Sato M."/>
<person name="Ozawa Y."/>
<person name="Kanmatsuse K."/>
<person name="Kokubun S."/>
</authorList>
<dbReference type="PubMed" id="11762699"/>
<dbReference type="DOI" id="10.1385/endo:15:3:277"/>
</citation>
<scope>VARIANT HHC1 GLU-557</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2001" name="Mol. Genet. Metab." volume="72" first="168" last="174">
<title>Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene.</title>
<authorList>
<person name="Cole D.E.C."/>
<person name="Vieth R."/>
<person name="Trang H.M."/>
<person name="Wong B.Y.-L."/>
<person name="Hendy G.N."/>
<person name="Rubin L.A."/>
</authorList>
<dbReference type="PubMed" id="11161843"/>
<dbReference type="DOI" id="10.1006/mgme.2000.3126"/>
</citation>
<scope>VARIANT SER-986</scope>
<scope>ASSOCIATION WITH SERUM LEVEL OF CALCIUM</scope>
<scope>PREDISPOSING FACTOR IN DISORDERS OF BONE AND MINERAL METABOLISM</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2002" name="J. Clin. Endocrinol. Metab." volume="87" first="2681" last="2687">
<title>A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium: identification of a novel gain of function mutation (Ser(820)Phe) in the calcium-sensing receptor.</title>
<authorList>
<person name="Nagase T."/>
<person name="Murakami T."/>
<person name="Tsukada T."/>
<person name="Kitamura R."/>
<person name="Chikatsu N."/>
<person name="Takeo H."/>
<person name="Takata N."/>
<person name="Yasuda H."/>
<person name="Fukumoto S."/>
<person name="Tanaka Y."/>
<person name="Nagata N."/>
<person name="Yamaguchi K."/>
<person name="Akatsu T."/>
<person name="Yamamoto M."/>
</authorList>
<dbReference type="PubMed" id="12050233"/>
<dbReference type="DOI" id="10.1210/jcem.87.6.8531"/>
</citation>
<scope>VARIANT HYPOC1 PHE-820</scope>
<scope>CHARACTERIZATION OF VARIANT HYPOC1 PHE-820</scope>
<scope>VARIANT GLY-990</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2002" name="J. Clin. Endocrinol. Metab." volume="87" first="3068" last="3073">
<title>Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene.</title>
<authorList>
<person name="Sato K."/>
<person name="Hasegawa Y."/>
<person name="Nakae J."/>
<person name="Nanao K."/>
<person name="Takahashi I."/>
<person name="Tajima T."/>
<person name="Shinohara N."/>
<person name="Fujieda K."/>
</authorList>
<dbReference type="PubMed" id="12107202"/>
<dbReference type="DOI" id="10.1210/jcem.87.7.8639"/>
</citation>
<scope>VARIANTS HYPOC1 PRO-125 AND GLU-843</scope>
<scope>CHARACTERIZATION OF VARIANTS HYPOC1 PRO-125 AND GLU-843</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2002" name="Lancet" volume="360" first="692" last="694">
<title>Association between activating mutations of calcium-sensing receptor and Bartter's syndrome.</title>
<authorList>
<person name="Watanabe S."/>
<person name="Fukumoto S."/>
<person name="Chang H."/>
<person name="Takeuchi Y."/>
<person name="Hasegawa Y."/>
<person name="Okazaki R."/>
<person name="Chikatsu N."/>
<person name="Fujita T."/>
</authorList>
<dbReference type="PubMed" id="12241879"/>
<dbReference type="DOI" id="10.1016/s0140-6736(02)09842-2"/>
</citation>
<scope>VARIANTS HYPOC1 TRP-131 AND GLU-843</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2003" name="J. Clin. Endocrinol. Metab." volume="88" first="605" last="610">
<title>Autosomal dominant hypocalcemia: a novel activating mutation (E604K) in the cysteine-rich domain of the calcium-sensing receptor.</title>
<authorList>
<person name="Tan Y.M."/>
<person name="Cardinal J."/>
<person name="Franks A.H."/>
<person name="Mun H.-C."/>
<person name="Lewis N."/>
<person name="Harris L.B."/>
<person name="Prins J.B."/>
<person name="Conigrave A.D."/>
</authorList>
<dbReference type="PubMed" id="12574188"/>
<dbReference type="DOI" id="10.1210/jc.2002-020081"/>
</citation>
<scope>VARIANT HYPOC1 LYS-604</scope>
<scope>CHARACTERIZATION OF VARIANT HYPOC1 LYS-604</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2003" name="J. Clin. Endocrinol. Metab." volume="88" first="3674" last="3681">
<title>Recurrent familial hypocalcemia due to germline mosaicism for an activating mutation of the calcium-sensing receptor gene.</title>
<authorList>
<person name="Hendy G.N."/>
<person name="Minutti C."/>
<person name="Canaff L."/>
<person name="Pidasheva S."/>
<person name="Yang B."/>
<person name="Nouhi Z."/>
<person name="Zimmerman D."/>
<person name="Wei C."/>
<person name="Cole D.E.C."/>
</authorList>
<dbReference type="PubMed" id="12915654"/>
<dbReference type="DOI" id="10.1210/jc.2003-030409"/>
</citation>
<scope>VARIANT HYPOC1 LEU-788</scope>
<scope>CHARACTERIZATION OF VARIANT HYPOC1 LEU-788</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2004" name="J. Clin. Endocrinol. Metab." volume="89" first="5634" last="5638">
<title>Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor.</title>
<authorList>
<person name="Scillitani A."/>
<person name="Guarnieri V."/>
<person name="De Geronimo S."/>
<person name="Muscarella L.A."/>
<person name="Battista C."/>
<person name="D'Agruma L."/>
<person name="Bertoldo F."/>
<person name="Florio C."/>
<person name="Minisola S."/>
<person name="Hendy G.N."/>
<person name="Cole D.E.C."/>
</authorList>
<dbReference type="PubMed" id="15531522"/>
<dbReference type="DOI" id="10.1210/jc.2004-0129"/>
</citation>
<scope>VARIANTS SER-986; GLY-990 AND GLN-1011</scope>
<scope>ASSOCIATION WITH SERUM LEVEL OF CALCIUM</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2004" name="J. Clin. Endocrinol. Metab." volume="89" first="5936" last="5941">
<title>Severe hypercalcemia in a 9-year-old Brazilian girl due to a novel inactivating mutation of the calcium-sensing receptor.</title>
<authorList>
<person name="Miyashiro K."/>
<person name="Kunii I."/>
<person name="Manna T.D."/>
<person name="de Menezes Filho H.C."/>
<person name="Damiani D."/>
<person name="Setian N."/>
<person name="Hauache O.M."/>
</authorList>
<dbReference type="PubMed" id="15579740"/>
<dbReference type="DOI" id="10.1210/jc.2004-1046"/>
</citation>
<scope>VARIANT HHC1 PRO-13</scope>
<scope>CHARACTERIZATION OF VARIANT HHC1 PRO-13</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2004" name="J. Med. Genet." volume="41" first="155" last="160">
<title>Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications.</title>
<authorList>
<person name="Warner J."/>
<person name="Epstein M."/>
<person name="Sweet A."/>
<person name="Singh D."/>
<person name="Burgess J."/>
<person name="Stranks S."/>
<person name="Hill P."/>
<person name="Perry-Keene D."/>
<person name="Learoyd D."/>
<person name="Robinson B."/>
<person name="Birdsey P."/>
<person name="Mackenzie E."/>
<person name="Teh B.T."/>
<person name="Prins J.B."/>
<person name="Cardinal J."/>
</authorList>
<dbReference type="PubMed" id="14985373"/>
<dbReference type="DOI" id="10.1136/jmg.2003.016725"/>
</citation>
<scope>VARIANTS NSHPT ILE-100; LYS-336 DEL; PRO-650 AND MET-689</scope>
<scope>VARIANTS SER-986; GLY-990 AND GLN-1011</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2005" name="Am. J. Med. Genet. A" volume="132" first="125" last="129">
<title>A novel mutation (E767K) in the second extracellular loop of the calcium sensing receptor in a family with autosomal dominant hypocalcemia.</title>
<authorList>
<person name="Uckun-Kitapci A."/>
<person name="Underwood L.E."/>
<person name="Zhang J."/>
<person name="Moats-Staats B."/>
</authorList>
<dbReference type="PubMed" id="15551332"/>
<dbReference type="DOI" id="10.1002/ajmg.a.30403"/>
</citation>
<scope>VARIANT HYPOC1 LYS-767</scope>
<scope>VARIANT GLY-990</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2005" name="Hum. Mol. Genet." volume="14" first="1679" last="1690">
<title>Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia.</title>
<authorList>
<person name="Pidasheva S."/>
<person name="Canaff L."/>
<person name="Simonds W.F."/>
<person name="Marx S.J."/>
<person name="Hendy G.N."/>
</authorList>
<dbReference type="PubMed" id="15879434"/>
<dbReference type="DOI" id="10.1093/hmg/ddi176"/>
</citation>
<scope>VARIANTS HHC1 SER-11 AND PRO-13</scope>
<scope>VARIANT ALA-14</scope>
<scope>CHARACTERIZATION OF VARIANTS HHC1 SER-11 AND PRO-13</scope>
<scope>CHARACTERIZATION OF VARIANT ALA-14</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2005" name="J. Clin. Endocrinol. Metab." volume="90" first="864" last="870">
<title>Functional characterization of calcium-sensing receptor codon 227 mutations presenting as either familial (benign) hypocalciuric hypercalcemia or neonatal hyperparathyroidism.</title>
<authorList>
<person name="Wystrychowski A."/>
<person name="Pidasheva S."/>
<person name="Canaff L."/>
<person name="Chudek J."/>
<person name="Kokot F."/>
<person name="Wiecek A."/>
<person name="Hendy G.N."/>
</authorList>
<dbReference type="PubMed" id="15572418"/>
<dbReference type="DOI" id="10.1210/jc.2004-1791"/>
</citation>
<scope>VARIANT HHC1 GLN-227</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT NSHPT LEU-227</scope>
<scope>CHARACTERIZATION OF VARIANT HHC1 GLN-227</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2006" name="Biochem. Biophys. Res. Commun." volume="342" first="996" last="1002">
<title>Identification of a novel inactivating R465Q mutation of the calcium-sensing receptor.</title>
<authorList>
<person name="Leech C."/>
<person name="Lohse P."/>
<person name="Stanojevic V."/>
<person name="Lechner A."/>
<person name="Goeke B."/>
<person name="Spitzweg C."/>
</authorList>
<dbReference type="PubMed" id="16598859"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2006.02.018"/>
</citation>
<scope>VARIANT HHC1 GLN-465</scope>
<scope>CHARACTERIZATION OF VARIANT HHC1 GLN-465</scope>
<scope>VARIANT SER-986</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2006" name="Hum. Mol. Genet." volume="15" first="2200" last="2209">
<title>Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly.</title>
<authorList>
<person name="Pidasheva S."/>
<person name="Grant M."/>
<person name="Canaff L."/>
<person name="Ercan O."/>
<person name="Kumar U."/>
<person name="Hendy G.N."/>
</authorList>
<dbReference type="PubMed" id="16740594"/>
<dbReference type="DOI" id="10.1093/hmg/ddl145"/>
</citation>
<scope>VARIANTS HHC1 CYS-66; HIS-66 AND 583-ASN--SER-1078 DEL</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>GLYCOSYLATION</scope>
<scope>CHARACTERIZATION OF VARIANTS CYS-66; HIS-66 AND 583-ASN--SER-1078 DEL</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2006" name="J. Clin. Endocrinol. Metab." volume="91" first="2474" last="2479">
<title>A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormone.</title>
<authorList>
<person name="Mittelman S.D."/>
<person name="Hendy G.N."/>
<person name="Fefferman R.A."/>
<person name="Canaff L."/>
<person name="Mosesova I."/>
<person name="Cole D.E."/>
<person name="Burkett L."/>
<person name="Geffner M.E."/>
</authorList>
<dbReference type="PubMed" id="16608894"/>
<dbReference type="DOI" id="10.1210/jc.2005-2605"/>
</citation>
<scope>VARIANT HYPOC1 GLN-727</scope>
<scope>CHARACTERIZATION OF VARIANT HYPOC1 GLN-727</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2007" name="J. Clin. Endocrinol. Metab." volume="92" first="2616" last="2623">
<title>Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status.</title>
<authorList>
<person name="Zajickova K."/>
<person name="Vrbikova J."/>
<person name="Canaff L."/>
<person name="Pawelek P.D."/>
<person name="Goltzman D."/>
<person name="Hendy G.N."/>
</authorList>
<dbReference type="PubMed" id="17473068"/>
<dbReference type="DOI" id="10.1210/jc.2007-0123"/>
</citation>
<scope>VARIANT HHC1 CYS-180</scope>
<scope>CHARACTERIZATION OF VARIANT HHC1 CYS-180</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2007" name="Clin. Endocrinol. (Oxf.)" volume="67" first="385" last="392">
<title>Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene.</title>
<authorList>
<person name="Toke J."/>
<person name="Czirjak G."/>
<person name="Patocs A."/>
<person name="Enyedi B."/>
<person name="Gergics P."/>
<person name="Csakvary V."/>
<person name="Enyedi P."/>
<person name="Toth M."/>
</authorList>
<dbReference type="PubMed" id="17555508"/>
<dbReference type="DOI" id="10.1111/j.1365-2265.2007.02896.x"/>
</citation>
<scope>VARIANT NSHPT LYS-551</scope>
<scope>VARIANT SER-986</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT NSHPT LYS-551</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2007" name="J. Clin. Endocrinol. Metab." volume="92" first="4373" last="4379">
<title>Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population.</title>
<authorList>
<person name="Nissen P.H."/>
<person name="Christensen S.E."/>
<person name="Heickendorff L."/>
<person name="Brixen K."/>
<person name="Mosekilde L."/>
</authorList>
<dbReference type="PubMed" id="17698911"/>
<dbReference type="DOI" id="10.1210/jc.2007-0322"/>
</citation>
<scope>VARIANTS HHC1 ARG-21; ASN-171; GLN-221; THR-225; PHE-271; ARG-397; ARG-509; ARG-553; VAL-555; TYR-562; PHE-582; TYR-582; ASP-623; ARG-670; PHE-728; ARG-742 AND TRP-886</scope>
<scope>VARIANTS LYS-250; SER-986; GLY-990 AND GLN-1011</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2008" name="Ann. Neurol." volume="64" first="158" last="167">
<title>An idiopathic epilepsy syndrome linked to 3q13.3-q21 and missense mutations in the extracellular calcium sensing receptor gene.</title>
<authorList>
<person name="Kapoor A."/>
<person name="Satishchandra P."/>
<person name="Ratnapriya R."/>
<person name="Reddy R."/>
<person name="Kadandale J."/>
<person name="Shankar S.K."/>
<person name="Anand A."/>
</authorList>
<dbReference type="PubMed" id="18756473"/>
<dbReference type="DOI" id="10.1002/ana.21428"/>
</citation>
<scope>VARIANTS EIG8 ALA-354; VAL-686; GLN-898; VAL-988 AND GLY-988</scope>
<scope>VARIANTS SER-986 AND GLY-990</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2009" name="J. Clin. Endocrinol. Metab." volume="94" first="4372" last="4379">
<title>A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia.</title>
<authorList>
<person name="Lietman S.A."/>
<person name="Tenenbaum-Rakover Y."/>
<person name="Jap T.S."/>
<person name="Yi-Chi W."/>
<person name="De-Ming Y."/>
<person name="Ding C."/>
<person name="Kussiny N."/>
<person name="Levine M.A."/>
</authorList>
<dbReference type="PubMed" id="19789209"/>
<dbReference type="DOI" id="10.1210/jc.2008-2484"/>
</citation>
<scope>VARIANT HHC1 ARG-459</scope>
<scope>VARIANTS SER-986 AND GLN-1011</scope>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANT HHC1 ARG-459</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2009" name="J. Mol. Endocrinol." volume="42" first="331" last="339">
<title>Calcium-sensing receptor mutations and denaturing high performance liquid chromatography.</title>
<authorList>
<person name="Cole D.E."/>
<person name="Yun F.H."/>
<person name="Wong B.Y."/>
<person name="Shuen A.Y."/>
<person name="Booth R.A."/>
<person name="Scillitani A."/>
<person name="Pidasheva S."/>
<person name="Zhou X."/>
<person name="Canaff L."/>
<person name="Hendy G.N."/>
</authorList>
<dbReference type="PubMed" id="19179454"/>
<dbReference type="DOI" id="10.1677/jme-08-0164"/>
</citation>
<scope>VARIANTS HHC1 SER-42; LEU-55; HIS-66; MET-81; MET-138; ARG-143; ARG-158; GLY-166; TRP-220; ARG-549; TYR-562; GLY-565; TYR-582; 583-ASN--SER-1078 DEL; TYR-661; HIS-680; ILE-761 DEL AND TRP-795</scope>
<scope>VARIANTS HYPOC1 LYS-118; PHE-125; ARG-129; LYS-228; LYS-604; ILE-802; SER-830; LEU-832 AND SER-832</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2010" name="Clin. Endocrinol. (Oxf.)" volume="73" first="715" last="722">
<title>A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia.</title>
<authorList>
<person name="Hannan F.M."/>
<person name="Nesbit M.A."/>
<person name="Christie P.T."/>
<person name="Lissens W."/>
<person name="Van der Schueren B."/>
<person name="Bex M."/>
<person name="Bouillon R."/>
<person name="Thakker R.V."/>
</authorList>
<dbReference type="PubMed" id="20846291"/>
<dbReference type="DOI" id="10.1111/j.1365-2265.2010.03870.x"/>
</citation>
<scope>VARIANT THR-339</scope>
<scope>CHARACTERIZATION OF VARIANT THR-339</scope>
<scope>INVOLVEMENT IN PRIMARY HYPERPARATHYROIDISM</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2011" name="Eur. J. Endocrinol." volume="165" first="359" last="363">
<title>A novel mutation in the calcium-sensing receptor in a French family with familial hypocalciuric hypercalcaemia.</title>
<authorList>
<person name="Al-Salameh A."/>
<person name="Cetani F."/>
<person name="Pardi E."/>
<person name="Vulpoi C."/>
<person name="Pierre P."/>
<person name="de Calan L."/>
<person name="Guyetant S."/>
<person name="Jeunemaitre X."/>
<person name="Lecomte P."/>
</authorList>
<dbReference type="PubMed" id="21566075"/>
<dbReference type="DOI" id="10.1530/eje-11-0141"/>
</citation>
<scope>VARIANT HHC1 ILE-550</scope>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANT HHC1 ILE-550</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RA78" last="RA78">
<title>Agonist-driven maturation and plasma membrane insertion of calcium-sensing receptors dynamically control signal amplitude.</title>
<authorList>
<person name="Grant M.P."/>
<person name="Stepanchick A."/>
<person name="Cavanaugh A."/>
<person name="Breitwieser G.E."/>
</authorList>
<dbReference type="PubMed" id="22114145"/>
<dbReference type="DOI" id="10.1126/scisignal.2002208"/>
</citation>
<scope>VARIANTS HHC1 PRO-159 AND TRP-795</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANTS HHC1 PRO-159 AND TRP-795</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2012" name="Eur. J. Pediatr." volume="171" first="147" last="150">
<title>Familial hypocalciuric hypercalcemia: new mutation in the CASR gene converting valine 697 to methionine.</title>
<authorList>
<person name="Aparicio Lopez C."/>
<person name="Anton-Martin P."/>
<person name="Gil-Fournier B."/>
<person name="Ramiro-Leon S."/>
<person name="Perez-Nanclares G."/>
<person name="Perez de Nanclares G."/>
<person name="Martinez Menendez B."/>
<person name="Castano L."/>
</authorList>
<dbReference type="PubMed" id="21643651"/>
<dbReference type="DOI" id="10.1007/s00431-011-1504-8"/>
</citation>
<scope>VARIANT HHC1 MET-697</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2013" name="J. Clin. Endocrinol. Metab." volume="98" first="E1692" last="E1701">
<title>Loss-of-function and gain-of-function mutations of calcium-sensing receptor: functional analysis and the effect of allosteric modulators NPS R-568 and NPS 2143.</title>
<authorList>
<person name="Nakamura A."/>
<person name="Hotsubo T."/>
<person name="Kobayashi K."/>
<person name="Mochizuki H."/>
<person name="Ishizu K."/>
<person name="Tajima T."/>
</authorList>
<dbReference type="PubMed" id="23966241"/>
<dbReference type="DOI" id="10.1210/jc.2013-1974"/>
</citation>
<scope>VARIANTS HHC1 THR-110 AND GLY-172</scope>
<scope>VARIANTS HYPOC1 CYS-122; HIS-569 AND THR-839</scope>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANTS HHC1 THR-110 AND GLY-172</scope>
<scope>CHARACTERIZATION OF VARIANTS HYPOC1 CYS-122; HIS-569 AND THR-839</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2013" name="Eur. J. Endocrinol." volume="168" first="K27" last="K34">
<title>Two novel mutations of the calcium-sensing receptor gene affecting the same amino acid position lead to opposite phenotypes and reveal the importance of p.N802 on receptor activity.</title>
<authorList>
<person name="Lia-Baldini A.S."/>
<person name="Magdelaine C."/>
<person name="Nizou A."/>
<person name="Airault C."/>
<person name="Salles J.P."/>
<person name="Moulin P."/>
<person name="Delemer B."/>
<person name="Aitouares M."/>
<person name="Funalot B."/>
<person name="Sturtz F."/>
<person name="Lienhardt-Roussie A."/>
</authorList>
<dbReference type="PubMed" id="23169696"/>
<dbReference type="DOI" id="10.1530/eje-12-0714"/>
</citation>
<scope>VARIANT HHC1 SER-802</scope>
<scope>VARIANT HYPOC1 ILE-802</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2014" name="BMC Endocr. Disord." volume="14" first="81" last="81">
<title>A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria.</title>
<authorList>
<person name="Mastromatteo E."/>
<person name="Lamacchia O."/>
<person name="Campo M.R."/>
<person name="Conserva A."/>
<person name="Baorda F."/>
<person name="Cinque L."/>
<person name="Guarnieri V."/>
<person name="Scillitani A."/>
<person name="Cignarelli M."/>
</authorList>
<dbReference type="PubMed" id="25292184"/>
<dbReference type="DOI" id="10.1186/1472-6823-14-81"/>
</citation>
<scope>VARIANT HHC1 MET-972</scope>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF VARIANT HHC1 MET-972</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2014" name="Nephrol. Dial. Transplant." volume="29" first="1902" last="1909">
<title>Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.</title>
<authorList>
<person name="Stratta P."/>
<person name="Merlotti G."/>
<person name="Musetti C."/>
<person name="Quaglia M."/>
<person name="Pagani A."/>
<person name="Izzo C."/>
<person name="Radin E."/>
<person name="Airoldi A."/>
<person name="Baorda F."/>
<person name="Palladino T."/>
<person name="Leone M.P."/>
<person name="Guarnieri V."/>
</authorList>
<dbReference type="PubMed" id="25104082"/>
<dbReference type="DOI" id="10.1093/ndt/gfu065"/>
</citation>
<scope>VARIANTS HHC1 VAL-707 AND SER-774</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANTS HHC1 VAL-707 AND SER-774</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2016" name="J. Bone Miner. Metab." volume="34" first="662" last="667">
<title>Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia.</title>
<authorList>
<person name="Kim E.S."/>
<person name="Kim S.Y."/>
<person name="Lee J.Y."/>
<person name="Han J.H."/>
<person name="Sohn T.S."/>
<person name="Son H.S."/>
<person name="Moon S.D."/>
</authorList>
<dbReference type="PubMed" id="26386835"/>
<dbReference type="DOI" id="10.1007/s00774-015-0713-z"/>
</citation>
<scope>VARIANT HHC1 TRP-571</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT HHC1 TRP-571</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2015" name="Mol. Cell. Endocrinol." volume="407" first="18" last="25">
<title>Novel activating mutation of human calcium-sensing receptor in a family with autosomal dominant hypocalcaemia.</title>
<authorList>
<person name="Baran N."/>
<person name="ter Braak M."/>
<person name="Saffrich R."/>
<person name="Woelfle J."/>
<person name="Schmitz U."/>
</authorList>
<dbReference type="PubMed" id="25766501"/>
<dbReference type="DOI" id="10.1016/j.mce.2015.02.021"/>
</citation>
<scope>VARIANT HYPOC1 LEU-136</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT HYPOC1 LEU-136</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2012" name="Mol. Genet. Metab." volume="107" first="548" last="552">
<title>CASR gene activating mutations in two families with autosomal dominant hypocalcemia.</title>
<authorList>
<person name="Guarnieri V."/>
<person name="Valentina D'Elia A."/>
<person name="Baorda F."/>
<person name="Pazienza V."/>
<person name="Benegiamo G."/>
<person name="Stanziale P."/>
<person name="Copetti M."/>
<person name="Battista C."/>
<person name="Grimaldi F."/>
<person name="Damante G."/>
<person name="Pellegrini F."/>
<person name="D'Agruma L."/>
<person name="Zelante L."/>
<person name="Carella M."/>
<person name="Scillitani A."/>
</authorList>
<dbReference type="PubMed" id="22789683"/>
<dbReference type="DOI" id="10.1016/j.ymgme.2012.06.012"/>
</citation>
<scope>VARIANTS HYPOC1 LEU-221; ARG-681 AND GLN-727</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANTS HYPOC1 ARG-681 AND GLN-727</scope>
</reference>
<comment type="function">
<text evidence="6 30 34 37 39 40 42 43 44 45 47 48 49 52 55 58 61">G-protein-coupled receptor that senses changes in the extracellular concentration of calcium ions and plays a key role in maintaining calcium homeostasis (PubMed:7759551, PubMed:8702647, PubMed:8636323, PubMed:8878438, PubMed:17555508, PubMed:19789209, PubMed:21566075, PubMed:22114145, PubMed:23966241, PubMed:25292184, PubMed:25104082, PubMed:26386835, PubMed:25766501, PubMed:22789683). Senses fluctuations in the circulating calcium concentration and modulates the production of parathyroid hormone (PTH) in parathyroid glands (By similarity). The activity of this receptor is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system (PubMed:7759551). The G-protein-coupled receptor activity is activated by a co-agonist mechanism: aromatic amino acids, such as Trp or Phe, act concertedly with divalent cations, such as calcium or magnesium, to achieve full receptor activation (PubMed:27434672, PubMed:27386547).</text>
</comment>
<comment type="activity regulation">
<text evidence="46 48 49">In resting state, adopts an open conformation, anion-binding promoting the inactive configuration (PubMed:27434672). Upon aromatic amino acid-binding, the groove in the extracellular venus flytrap module is closed, thereby inducing the formation of a novel homodimer interface between subunits (PubMed:27434672, PubMed:27386547). Calcium ions stabilize the active state by enhancing homodimer interactions between membrane-proximal domains to fully activate the receptor (PubMed:27434672, PubMed:27386547). Activated by AMG 416, a D-amino acid-containing peptide agonist that is being evaluated for the treatment of secondary hyperparathyroidism in chronic kidney disease patients receiving hemodialysis (PubMed:26290606). AMG 416 agonist acts by forming a disulfide bond with Cys-482 (PubMed:26290606).</text>
</comment>
<comment type="subunit">
<text evidence="5 25 28 48 49">Homodimer; disulfide-linked (PubMed:27434672, PubMed:27386547, PubMed:16740594). Interacts with VCP and RNF19A (PubMed:16513638). Interacts with ARRB1 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4400127">
<id>P41180</id>
</interactant>
<interactant intactId="EBI-998485">
<id>Q15363</id>
<label>TMED2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="22 28 30 34 36 39 40 43 45 47 58">Cell membrane</location>
<topology evidence="36">Multi-pass membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P41180-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P41180-2</id>
<name>2</name>
<sequence type="described" ref="VSP_002035"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="32">Expressed in the temporal lobe, frontal lobe, parietal lobe, hippocampus, and cerebellum. Also found in kidney, lung, liver, heart, skeletal muscle, placenta.</text>
</comment>
<comment type="domain">
<text evidence="48 49 68">The extracellular regions of the homodimer interact in a side-by-side fashion while facing opposite directions (PubMed:27434672, PubMed:27386547). Each extracellular region consists of three domains, LB1 (ligand-binding 1), LB2 and CR (cysteine-rich) (PubMed:17360426). The two lobe-shaped domains LB1 and LB2 form a venus flytrap module (PubMed:27434672, PubMed:27386547). In the inactive configuration, the venus flytrap modules of both protomers are in the open conformation associated with the resting state (open-open) and the interdomain cleft is empty (PubMed:27434672). In addition, each protomer contains three anions, which reinforce the inactive conformation, and one calcium ion (PubMed:27434672). In the active configuration, both protomers of extracellular regions have the closed conformation associated with agonist-binding (closed-closed) (PubMed:27434672, PubMed:27386547). The ligand-binding cleft of each protomer is solely occupied by an aromatic amino-acid (PubMed:27434672, PubMed:27386547). Calcium is bound at four novel sites, including one at the homodimer interface (PubMed:27434672, PubMed:27386547). Agonist-binding induces large conformational changes within the extracellular region homodimer: first, the venus flytrap module of each protomer undergoes domain closure (PubMed:27434672, PubMed:27386547). Second, the LB2 regions of the two protomers approach each other, resulting in an expansion of the homodimer interactions involving LB2 domains (PubMed:27434672, PubMed:27386547). Third, the CR regions of the two subunits interact to form a large homodimer interface that is unique to the active state (PubMed:27434672, PubMed:27386547). The CR regions are brought into close contact by the motion involving LB2 since the two domains are rigidly associated within each subunit (PubMed:27434672, PubMed:27386547).</text>
</comment>
<comment type="PTM">
<text evidence="25 28 36 49 58">N-glycosylated.</text>
</comment>
<comment type="PTM">
<text evidence="25">Ubiquitinated by RNF19A; which induces proteasomal degradation.</text>
</comment>
<comment type="disease" evidence="13 22 23 24 26 28 29 31 33 34 37 38 39 41 42 43 44 47 49 50 51 54 55 58 61 64">
<disease id="DI-01588">
<name>Hypocalciuric hypercalcemia, familial 1</name>
<acronym>HHC1</acronym>
<description>A form of hypocalciuric hypercalcemia, a disorder of mineral homeostasis that is transmitted as an autosomal dominant trait with a high degree of penetrance. It is characterized biochemically by lifelong elevation of serum calcium concentrations and is associated with inappropriately low urinary calcium excretion and a normal or mildly elevated circulating parathyroid hormone level. Hypermagnesemia is typically present. Affected individuals are usually asymptomatic and the disorder is considered benign. However, chondrocalcinosis and pancreatitis occur in some adults.</description>
<dbReference type="MIM" id="145980"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="19 22 30 49 56 61 63">
<disease id="DI-02039">
<name>Hyperparathyroidism, neonatal severe</name>
<acronym>NSHPT</acronym>
<description>A disorder characterized by severe hypercalcemia, bone demineralization, and failure to thrive usually manifesting in the first 6 months of life. If untreated, NSHPT can be a devastating neurodevelopmental disorder, which in some cases is lethal without parathyroidectomy.</description>
<dbReference type="MIM" id="239200"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="10 14 15 16 17 18 21 27 33 40 41 42 45 53 58 59 60 61 62 65 66">
<disease id="DI-03841">
<name>Hypocalcemia, autosomal dominant 1</name>
<acronym>HYPOC1</acronym>
<description>A disorder of mineral homeostasis characterized by blood calcium levels below normal, and low or normal serum parathyroid hormone concentrations. Disease manifestations include mild or asymptomatic hypocalcemia, paresthesias, carpopedal spasm, seizures, hypercalciuria with nephrocalcinosis or kidney stones, and ectopic and basal ganglia calcifications. Few patients manifest hypocalcemia and features of Bartter syndrome, including hypomagnesemia, hypokalemia, metabolic alkalosis, hyperreninemia, and hyperaldosteronemia.</description>
<dbReference type="MIM" id="601198"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="32">
<disease id="DI-02484">
<name>Epilepsy, idiopathic generalized 8</name>
<acronym>EIG8</acronym>
<description>A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Seizure types are variable, but include myoclonic seizures, absence seizures, febrile seizures, complex partial seizures, and generalized tonic-clonic seizures.</description>
<dbReference type="MIM" id="612899"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="73">Belongs to the G-protein coupled receptor 3 family.</text>
</comment>
<comment type="sequence caution" evidence="73">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAB29413" version="2"/>
</conflict>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/casr/"/>
</comment>
<dbReference type="EMBL" id="X81086">
<property type="protein sequence ID" value="CAA56990.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U20759">
<property type="protein sequence ID" value="AAA86503.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U20760">
<property type="protein sequence ID" value="AAA86504.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D50855">
<property type="protein sequence ID" value="BAA09453.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S83176">
<property type="protein sequence ID" value="AAB46873.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S79217">
<property type="protein sequence ID" value="AAB35262.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S81755">
<property type="protein sequence ID" value="AAD14370.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S68032">
<property type="protein sequence ID" value="AAB29413.2"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S68033">
<property type="protein sequence ID" value="AAB29414.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S68036">
<property type="protein sequence ID" value="AAB29415.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ088967">
<property type="protein sequence ID" value="AAY68221.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC104999">
<property type="protein sequence ID" value="AAI05000.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC112236">
<property type="protein sequence ID" value="AAI12237.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3010.1">
<molecule id="P41180-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54632.1">
<molecule id="P41180-2"/>
</dbReference>
<dbReference type="PIR" id="A56715">
<property type="entry name" value="A56715"/>
</dbReference>
<dbReference type="PIR" id="B56715">
<property type="entry name" value="B56715"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000379.2">
<molecule id="P41180-1"/>
<property type="nucleotide sequence ID" value="NM_000388.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171536.1">
<molecule id="P41180-2"/>
<property type="nucleotide sequence ID" value="NM_001178065.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006713852.1">
<molecule id="P41180-1"/>
<property type="nucleotide sequence ID" value="XM_006713789.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016862813.1">
<molecule id="P41180-1"/>
<property type="nucleotide sequence ID" value="XM_017007324.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016862814.1">
<molecule id="P41180-1"/>
<property type="nucleotide sequence ID" value="XM_017007325.1"/>
</dbReference>
<dbReference type="PDB" id="5FBH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=20-541"/>
</dbReference>
<dbReference type="PDB" id="5FBK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=20-541"/>
</dbReference>
<dbReference type="PDB" id="5K5S">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=20-607"/>
</dbReference>
<dbReference type="PDB" id="5K5T">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=20-607"/>
</dbReference>
<dbReference type="PDBsum" id="5FBH"/>
<dbReference type="PDBsum" id="5FBK"/>
<dbReference type="PDBsum" id="5K5S"/>
<dbReference type="PDBsum" id="5K5T"/>
<dbReference type="SMR" id="P41180"/>
<dbReference type="BioGRID" id="107296">
<property type="interactions" value="19"/>
</dbReference>
<dbReference type="DIP" id="DIP-5975N"/>
<dbReference type="ELM" id="P41180"/>
<dbReference type="IntAct" id="P41180">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000420194"/>
<dbReference type="BindingDB" id="P41180"/>
<dbReference type="ChEMBL" id="CHEMBL1878"/>
<dbReference type="DrugBank" id="DB11093">
<property type="generic name" value="Calcium citrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB11348">
<property type="generic name" value="Calcium Phosphate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14481">
<property type="generic name" value="Calcium phosphate dihydrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01012">
<property type="generic name" value="Cinacalcet"/>
</dbReference>
<dbReference type="DrugBank" id="DB12865">
<property type="generic name" value="Etelcalcetide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00994">
<property type="generic name" value="Neomycin"/>
</dbReference>
<dbReference type="DrugBank" id="DB05695">
<property type="generic name" value="NPS-2143"/>
</dbReference>
<dbReference type="DrugBank" id="DB05255">
<property type="generic name" value="Ronacaleret"/>
</dbReference>
<dbReference type="DrugBank" id="DB00127">
<property type="generic name" value="Spermine"/>
</dbReference>
<dbReference type="DrugCentral" id="P41180"/>
<dbReference type="GuidetoPHARMACOLOGY" id="54"/>
<dbReference type="TCDB" id="9.A.14.7.2">
<property type="family name" value="the g-protein-coupled receptor (gpcr) family"/>
</dbReference>
<dbReference type="GlyConnect" id="1227">
<property type="glycosylation" value="2 N-Linked glycans (1 site)"/>
</dbReference>
<dbReference type="GlyGen" id="P41180">
<property type="glycosylation" value="11 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P41180"/>
<dbReference type="PhosphoSitePlus" id="P41180"/>
<dbReference type="BioMuta" id="CASR"/>
<dbReference type="DMDM" id="1168781"/>
<dbReference type="MassIVE" id="P41180"/>
<dbReference type="PaxDb" id="P41180"/>
<dbReference type="PeptideAtlas" id="P41180"/>
<dbReference type="PRIDE" id="P41180"/>
<dbReference type="ProteomicsDB" id="55410">
<molecule id="P41180-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55411">
<molecule id="P41180-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="16753">
<property type="antibodies" value="663 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000498619">
<molecule id="P41180-2"/>
<property type="protein sequence ID" value="ENSP00000420194"/>
<property type="gene ID" value="ENSG00000036828"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000638421">
<molecule id="P41180-1"/>
<property type="protein sequence ID" value="ENSP00000492190"/>
<property type="gene ID" value="ENSG00000036828"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000639785">
<molecule id="P41180-1"/>
<property type="protein sequence ID" value="ENSP00000491584"/>
<property type="gene ID" value="ENSG00000036828"/>
</dbReference>
<dbReference type="GeneID" id="846"/>
<dbReference type="KEGG" id="hsa:846"/>
<dbReference type="UCSC" id="uc003eev.5">
<molecule id="P41180-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="846"/>
<dbReference type="DisGeNET" id="846"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000036828.13"/>
<dbReference type="GeneCards" id="CASR"/>
<dbReference type="GeneReviews" id="CASR"/>
<dbReference type="HGNC" id="HGNC:1514">
<property type="gene designation" value="CASR"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000036828">
<property type="expression patterns" value="Tissue enriched (parathyroid)"/>
</dbReference>
<dbReference type="MalaCards" id="CASR"/>
<dbReference type="MIM" id="145980">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="239200">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601198">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601199">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="612899">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P41180"/>
<dbReference type="OpenTargets" id="ENSG00000036828"/>
<dbReference type="Orphanet" id="428">
<property type="disease" value="Autosomal dominant hypocalcemia"/>
</dbReference>
<dbReference type="Orphanet" id="93372">
<property type="disease" value="Familial hypocalciuric hypercalcemia type 1"/>
</dbReference>
<dbReference type="Orphanet" id="676">
<property type="disease" value="Hereditary chronic pancreatitis"/>
</dbReference>
<dbReference type="Orphanet" id="417">
<property type="disease" value="Neonatal severe primary hyperparathyroidism"/>
</dbReference>
<dbReference type="PharmGKB" id="PA26097"/>
<dbReference type="eggNOG" id="KOG1056">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157596"/>
<dbReference type="HOGENOM" id="CLU_005389_0_0_1"/>
<dbReference type="InParanoid" id="P41180"/>
<dbReference type="KO" id="K04612"/>
<dbReference type="OMA" id="KKILWSG"/>
<dbReference type="OrthoDB" id="327938at2759"/>
<dbReference type="PhylomeDB" id="P41180"/>
<dbReference type="PathwayCommons" id="P41180"/>
<dbReference type="Reactome" id="R-HSA-416476">
<property type="pathway name" value="G alpha (q) signalling events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418594">
<property type="pathway name" value="G alpha (i) signalling events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-420499">
<property type="pathway name" value="Class C/3 (Metabotropic glutamate/pheromone receptors)"/>
</dbReference>
<dbReference type="SIGNOR" id="P41180"/>
<dbReference type="BioGRID-ORCS" id="846">
<property type="hits" value="24 hits in 873 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CASR">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Calcium-sensing_receptor"/>
<dbReference type="GenomeRNAi" id="846"/>
<dbReference type="Pharos" id="P41180">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P41180"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="RNAct" id="P41180">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000036828">
<property type="expression patterns" value="Expressed in islet of Langerhans and 99 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P41180">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P41180">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043679">
<property type="term" value="C:axon terminus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043025">
<property type="term" value="C:neuronal cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016597">
<property type="term" value="F:amino acid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004930">
<property type="term" value="F:G protein-coupled receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005178">
<property type="term" value="F:integrin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044325">
<property type="term" value="F:ion channel binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004435">
<property type="term" value="F:phosphatidylinositol phospholipase C activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007193">
<property type="term" value="P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009653">
<property type="term" value="P:anatomical structure morphogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032782">
<property type="term" value="P:bile acid secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048754">
<property type="term" value="P:branching morphogenesis of an epithelial tube"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070509">
<property type="term" value="P:calcium ion import"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006874">
<property type="term" value="P:cellular calcium ion homeostasis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071333">
<property type="term" value="P:cellular response to glucose stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035729">
<property type="term" value="P:cellular response to hepatocyte growth factor stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071404">
<property type="term" value="P:cellular response to low-density lipoprotein particle stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901653">
<property type="term" value="P:cellular response to peptide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071305">
<property type="term" value="P:cellular response to vitamin D"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007635">
<property type="term" value="P:chemosensory behavior"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:1902476">
<property type="term" value="P:chloride transmembrane transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005513">
<property type="term" value="P:detection of calcium ion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060613">
<property type="term" value="P:fat pad development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007254">
<property type="term" value="P:JNK cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001503">
<property type="term" value="P:ossification"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007200">
<property type="term" value="P:phospholipase C-activating G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032781">
<property type="term" value="P:positive regulation of ATPase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090280">
<property type="term" value="P:positive regulation of calcium ion import"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032024">
<property type="term" value="P:positive regulation of insulin secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050927">
<property type="term" value="P:positive regulation of positive chemotaxis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045907">
<property type="term" value="P:positive regulation of vasoconstriction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051924">
<property type="term" value="P:regulation of calcium ion transport"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071774">
<property type="term" value="P:response to fibroblast growth factor"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002931">
<property type="term" value="P:response to ischemia"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042311">
<property type="term" value="P:vasodilation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="2.10.50.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001828">
<property type="entry name" value="ANF_lig-bd_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR000337">
<property type="entry name" value="GPCR_3"/>
</dbReference>
<dbReference type="InterPro" id="IPR011500">
<property type="entry name" value="GPCR_3_9-Cys_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR038550">
<property type="entry name" value="GPCR_3_9-Cys_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR017978">
<property type="entry name" value="GPCR_3_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR000068">
<property type="entry name" value="GPCR_3_Ca_sens_rcpt-rel"/>
</dbReference>
<dbReference type="InterPro" id="IPR017979">
<property type="entry name" value="GPCR_3_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR028082">
<property type="entry name" value="Peripla_BP_I"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24061">
<property type="entry name" value="PTHR24061"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00003">
<property type="entry name" value="7tm_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01094">
<property type="entry name" value="ANF_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07562">
<property type="entry name" value="NCD3G"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00592">
<property type="entry name" value="CASENSINGR"/>
</dbReference>
<dbReference type="PRINTS" id="PR00248">
<property type="entry name" value="GPCRMGR"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF53822">
<property type="entry name" value="SSF53822"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00979">
<property type="entry name" value="G_PROTEIN_RECEP_F3_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00980">
<property type="entry name" value="G_PROTEIN_RECEP_F3_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00981">
<property type="entry name" value="G_PROTEIN_RECEP_F3_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50259">
<property type="entry name" value="G_PROTEIN_RECEP_F3_4"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0297">G-protein coupled receptor</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0807">Transducer</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="7">
<location>
<begin position="1"/>
<end position="19"/>
</location>
</feature>
<feature type="chain" description="Extracellular calcium-sensing receptor" id="PRO_0000012946">
<location>
<begin position="20"/>
<end position="1078"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="7">
<location>
<begin position="20"/>
<end position="612"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=1" evidence="7">
<location>
<begin position="613"/>
<end position="635"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="7">
<location>
<begin position="636"/>
<end position="649"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=2" evidence="7">
<location>
<begin position="650"/>
<end position="670"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="7">
<location>
<begin position="671"/>
<end position="681"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=3" evidence="7">
<location>
<begin position="682"/>
<end position="700"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="7">
<location>
<begin position="701"/>
<end position="724"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=4" evidence="7">
<location>
<begin position="725"/>
<end position="745"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="7">
<location>
<begin position="746"/>
<end position="769"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=5" evidence="7">
<location>
<begin position="770"/>
<end position="792"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="7">
<location>
<begin position="793"/>
<end position="805"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=6" evidence="7">
<location>
<begin position="806"/>
<end position="828"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="7">
<location>
<begin position="829"/>
<end position="836"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=7" evidence="7">
<location>
<begin position="837"/>
<end position="862"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="7">
<location>
<begin position="863"/>
<end position="1078"/>
</location>
</feature>
<feature type="region of interest" description="Ligand-binding 1 (LB1)" evidence="68">
<location>
<begin position="22"/>
<end position="188"/>
</location>
</feature>
<feature type="region of interest" description="Anion binding" evidence="3 4 49">
<location>
<begin position="66"/>
<end position="70"/>
</location>
</feature>
<feature type="region of interest" description="Ligand-binding 2 (LB2)" evidence="68">
<location>
<begin position="189"/>
<end position="324"/>
</location>
</feature>
<feature type="region of interest" description="Anion binding" evidence="3 4 49">
<location>
<begin position="415"/>
<end position="417"/>
</location>
</feature>
<feature type="region of interest" description="Cysteine-rich (CR)" evidence="68">
<location>
<begin position="542"/>
<end position="612"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RNF19A" evidence="25">
<location>
<begin position="880"/>
<end position="900"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium; via carbonyl oxygen" evidence="1 2 3 49 74">
<location>
<position position="81"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="2 3 49 74">
<location>
<position position="84"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium; via carbonyl oxygen" evidence="1 2 3 49 74">
<location>
<position position="87"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium; via carbonyl oxygen" evidence="1 2 3 49 74">
<location>
<position position="88"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="3 4 49">
<location>
<position position="100"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="3 49">
<location>
<position position="145"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="3 49">
<location>
<position position="231"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium" evidence="3 49">
<location>
<position position="234"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium; via carbonyl oxygen" evidence="3 49">
<location>
<position position="557"/>
</location>
</feature>
<feature type="binding site" description="Aromatic amino acid" evidence="1 2 3 48 49">
<location>
<position position="147"/>
</location>
</feature>
<feature type="binding site" description="Aromatic amino acid; via carbonyl oxygen" evidence="1 2 3 48 49">
<location>
<position position="168"/>
</location>
</feature>
<feature type="binding site" description="Aromatic amino acid" evidence="1 2 3 48 49">
<location>
<position position="170"/>
</location>
</feature>
<feature type="binding site" description="Aromatic amino acid" evidence="1 2 3 48 49">
<location>
<position position="297"/>
</location>
</feature>
<feature type="site" description="Important for ability of agonist AMG 416 to activate G-protein-coupled receptor activity" evidence="46">
<location>
<position position="482"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="920"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="1061"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="90"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="130"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 49">
<location>
<position position="261"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 49">
<location>
<position position="287"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="386"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="400"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 49">
<location>
<position position="446"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 49">
<location>
<position position="468"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 49">
<location>
<position position="488"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 49">
<location>
<position position="541"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 49">
<location>
<position position="594"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 48 49">
<location>
<begin position="60"/>
<end position="101"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain" evidence="49 74">
<location>
<position position="129"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain" evidence="49 74">
<location>
<position position="131"/>
</location>
</feature>
<feature type="disulfide bond" evidence="49">
<location>
<begin position="236"/>
<end position="561"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 48 49">
<location>
<begin position="358"/>
<end position="395"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 48 49">
<location>
<begin position="437"/>
<end position="449"/>
</location>
</feature>
<feature type="disulfide bond" evidence="49">
<location>
<begin position="542"/>
<end position="562"/>
</location>
</feature>
<feature type="disulfide bond" evidence="49">
<location>
<begin position="546"/>
<end position="565"/>
</location>
</feature>
<feature type="disulfide bond" evidence="49">
<location>
<begin position="568"/>
<end position="582"/>
</location>
</feature>
<feature type="disulfide bond" evidence="49">
<location>
<begin position="585"/>
<end position="598"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002035" evidence="70">
<original>E</original>
<variation>EPLTFVLSVLQ</variation>
<location>
<position position="536"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; demonstrates reduced intracellular and plasma membrane expression and signaling to the MAPK pathway in response to extracellular calcium relative to wild-type; fails to be inserted in the microsomes and does not undergo proper glycosylation; dbSNP:rs200673016." id="VAR_058046" evidence="24">
<original>L</original>
<variation>S</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; has a dose-response curve shifted to the right relative to that of wild-type; demonstrates reduced intracellular and plasma membrane expression and signaling to the MAPK pathway in response to extracellular calcium relative to wild-type; fails to be inserted in the microsomes and does not undergo proper glycosylation; dbSNP:rs104893717." id="VAR_058047" evidence="23 24">
<original>L</original>
<variation>P</variation>
<location>
<position position="13"/>
</location>
</feature>
<feature type="sequence variant" description="Does not demonstrate reduced intracellular and plasma membrane expression and signaling to the MAPK pathway in response to extracellular calcium relative to wild-type; does not fail to be inserted in the microsomes and does undergo proper glycosylation; dbSNP:rs199515839." id="VAR_058048" evidence="24">
<original>T</original>
<variation>A</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; dbSNP:rs1064794290." id="VAR_058049" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with primary hyperparathyroidism detected at adulthood; mutant CASR is activated by a higher calcium concentrations than the wild-type." id="VAR_065198" evidence="9">
<original>Q</original>
<variation>R</variation>
<location>
<position position="27"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; dbSNP:rs121909262." id="VAR_003585" evidence="50">
<original>P</original>
<variation>A</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; dbSNP:rs1553765909." id="VAR_078139" evidence="33">
<original>F</original>
<variation>S</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; the EC(50) of the mutant is significantly lower than that of wild-type; dbSNP:rs104893702." id="VAR_058050" evidence="66">
<original>K</original>
<variation>N</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway." id="VAR_078140" evidence="55">
<original>S</original>
<variation>P</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs886041154." id="VAR_078141" evidence="33 55 61">
<original>P</original>
<variation>L</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; mild; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909265." id="VAR_003586" evidence="51 58">
<original>R</original>
<variation>M</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; does not affect homodimerization; impaired N-glycosylation; impaired cell membrane localization; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909266." id="VAR_003587" evidence="28 51 58">
<original>R</original>
<variation>C</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; does not affect homodimerization; impaired N-glycosylation; impaired cell membrane localization; decreased G-protein coupled receptor signaling pathway; dbSNP:rs1276839362." id="VAR_078142" evidence="28 33 49">
<original>R</original>
<variation>H</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway." id="VAR_078143" evidence="33 49">
<original>I</original>
<variation>M</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence variant" description="In NSHPT; Abolished G-protein coupled receptor activity." id="VAR_065199" evidence="19 49">
<original>T</original>
<variation>I</variation>
<location>
<position position="100"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway." id="VAR_078144" evidence="42">
<original>A</original>
<variation>T</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; dbSNP:rs104893691." id="VAR_003588" evidence="59">
<original>A</original>
<variation>T</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; the mutation shifts the concentration-response curve to the left and increases maximal activity; dbSNP:rs104893695." id="VAR_058051" evidence="33 60 62">
<original>N</original>
<variation>K</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; increased G-protein coupled receptor signaling pathway." id="VAR_078145" evidence="42">
<original>S</original>
<variation>C</variation>
<location>
<position position="122"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1." id="VAR_078146" evidence="33">
<original>L</original>
<variation>F</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; shifts the concentration-response curve of calcium ions to the left; dbSNP:rs104893708." id="VAR_058052" evidence="15">
<original>L</original>
<variation>P</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; increased G-protein coupled receptor signaling pathway; dbSNP:rs121909260." id="VAR_003589" evidence="53 58">
<original>E</original>
<variation>A</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; increased G-protein coupled receptor signaling pathway; dbSNP:rs104893696." id="VAR_058053" evidence="60 61">
<original>F</original>
<variation>L</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1." id="VAR_078147" evidence="33">
<original>C</original>
<variation>R</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; associated with clinical features of Bartter syndrome; dbSNP:rs121909267." id="VAR_058054" evidence="16">
<original>C</original>
<variation>W</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; increased G-protein coupled receptor signaling pathway; does not affect cell membrane localization." id="VAR_078148" evidence="45">
<original>P</original>
<variation>L</variation>
<location>
<position position="136"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909263." id="VAR_003590" evidence="33 51 58">
<original>T</original>
<variation>M</variation>
<location>
<position position="138"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909264." id="VAR_003591" evidence="51 58">
<original>G</original>
<variation>E</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; dbSNP:rs769256610." id="VAR_078149" evidence="33">
<original>G</original>
<variation>R</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; increased G-protein coupled receptor signaling pathway; dbSNP:rs104893694." id="VAR_058055" evidence="57 60 61">
<original>T</original>
<variation>M</variation>
<location>
<position position="151"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_078150" evidence="33">
<original>G</original>
<variation>R</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway." id="VAR_078151" evidence="39 49">
<original>L</original>
<variation>P</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; dbSNP:rs193922441." id="VAR_078152" evidence="33">
<original>S</original>
<variation>G</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_058056" evidence="31">
<original>S</original>
<variation>N</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs201851934." id="VAR_078153" evidence="42 49">
<original>R</original>
<variation>G</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_003592" evidence="64">
<original>L</original>
<variation>R</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs1060502855." id="VAR_078154" evidence="61">
<original>N</original>
<variation>D</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; although the mutant receptor is expressed normally at the cell surface it is unresponsive with respect to intracellular signaling (MAPK activation) to increases in extracellular calcium concentrations; dbSNP:rs121909268." id="VAR_058057" evidence="29">
<original>F</original>
<variation>C</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs104893689." id="VAR_003593" evidence="54 55 58">
<original>R</original>
<variation>Q</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; increased G-protein coupled receptor signaling pathway; dbSNP:rs104893697." id="VAR_058058" evidence="60 61">
<original>E</original>
<variation>K</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway." id="VAR_078155" evidence="49 55">
<original>D</original>
<variation>G</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; dbSNP:rs1482119762." id="VAR_078156" evidence="33">
<original>R</original>
<variation>W</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; dbSNP:rs397514728." id="VAR_078157" evidence="40">
<original>P</original>
<variation>L</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; dbSNP:rs397514728." id="VAR_058059" evidence="31">
<original>P</original>
<variation>Q</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway." id="VAR_078158" evidence="61">
<original>P</original>
<variation>S</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_058060" evidence="31">
<original>K</original>
<variation>T</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In NSHPT; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization; dbSNP:rs28936684." id="VAR_003594" evidence="22 49 56 61">
<original>R</original>
<variation>L</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; G-protein coupled receptor signaling pathway; less markedly impaired relative to wild-type than L-227; does not affect cell membrane localization; dbSNP:rs28936684." id="VAR_003595" evidence="22 51">
<original>R</original>
<variation>Q</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1." id="VAR_078159" evidence="33">
<original>E</original>
<variation>K</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs62269092." id="VAR_058061" evidence="31">
<original>E</original>
<variation>K</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_058062" evidence="31">
<original>S</original>
<variation>F</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909259." id="VAR_003596" evidence="49 54 58">
<original>E</original>
<variation>K</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="sequence variant" description="In NSHPT." id="VAR_065200" evidence="19">
<location>
<position position="336"/>
</location>
</feature>
<feature type="sequence variant" description="Mutation found in a patient with primary hyperparathyroidism detected at adulthood; inactivating mutation; mutant CASR is activated by a higher calcium concentrations than the wild-type." id="VAR_065201" evidence="35">
<original>P</original>
<variation>T</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="sequence variant" description="In EIG8; patients present juvenile myoclonus epilepsy." id="VAR_060206" evidence="32">
<original>E</original>
<variation>A</variation>
<location>
<position position="354"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; dbSNP:rs1064794291." id="VAR_058063" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="397"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization." id="VAR_078160" evidence="34">
<original>Q</original>
<variation>R</variation>
<location>
<position position="459"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; loss-of-function mutation; the quantity of the mutant receptor is higher than that of the wild-type receptor; dose-response curves show that the mutation significantly reduces the sensitivity of the receptor to extracellular calcium concentrations; dbSNP:rs104893716." id="VAR_058064" evidence="26">
<original>R</original>
<variation>Q</variation>
<location>
<position position="465"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; dbSNP:rs193922423." id="VAR_058065" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="509"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_078161" evidence="33">
<original>G</original>
<variation>R</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway." id="VAR_078162" evidence="37">
<original>T</original>
<variation>I</variation>
<location>
<position position="550"/>
</location>
</feature>
<feature type="sequence variant" description="In NSHPT; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization; dbSNP:rs1060502861." id="VAR_078163" evidence="30 49">
<original>R</original>
<variation>K</variation>
<location>
<position position="551"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; dbSNP:rs104893719." id="VAR_058066" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="553"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; dbSNP:rs777646067." id="VAR_058067" evidence="31">
<original>I</original>
<variation>V</variation>
<location>
<position position="555"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; Abolished G-protein coupled receptor activity." id="VAR_012649" evidence="13 49">
<original>G</original>
<variation>E</variation>
<location>
<position position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_058068" evidence="31 33">
<original>C</original>
<variation>Y</variation>
<location>
<position position="562"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_078164" evidence="33">
<original>C</original>
<variation>G</variation>
<location>
<position position="565"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; increased G-protein coupled receptor signaling pathway." id="VAR_078165" evidence="42">
<original>P</original>
<variation>H</variation>
<location>
<position position="569"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization." id="VAR_078166" evidence="47">
<original>G</original>
<variation>W</variation>
<location>
<position position="571"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; dbSNP:rs104893690." id="VAR_058069" evidence="31">
<original>C</original>
<variation>F</variation>
<location>
<position position="582"/>
</location>
</feature>
<feature type="sequence variant" description="In NSHPT and HHC1; dbSNP:rs104893690." id="VAR_003597" evidence="31 33 56">
<original>C</original>
<variation>Y</variation>
<location>
<position position="582"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; impaired homodimerization; impaired cell membrane localization." id="VAR_078167" evidence="28 33">
<location>
<begin position="583"/>
<end position="1078"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; there is a significant leftward shift in the concentration response curves for the effects of extracellular calcium on both intracellular calcium mobilization and MAPK activity; dbSNP:rs104893712." id="VAR_058070" evidence="17 33">
<original>E</original>
<variation>K</variation>
<location>
<position position="604"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; dbSNP:rs104893698." id="VAR_058071" evidence="60">
<original>F</original>
<variation>S</variation>
<location>
<position position="612"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; does not affect the total accumulation of inositol phosphates as a function of extracellular calcium concentrations in transfected cells; dbSNP:rs104893703." id="VAR_015414" evidence="10">
<original>L</original>
<variation>V</variation>
<location>
<position position="616"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_058072" evidence="31">
<original>G</original>
<variation>D</variation>
<location>
<position position="623"/>
</location>
</feature>
<feature type="sequence variant" description="In NSHPT." id="VAR_065202" evidence="19">
<original>L</original>
<variation>P</variation>
<location>
<position position="650"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_078168" evidence="55">
<original>S</original>
<variation>Y</variation>
<location>
<position position="657"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_078169" evidence="33">
<original>C</original>
<variation>Y</variation>
<location>
<position position="661"/>
</location>
</feature>
<feature type="sequence variant" description="In NSHPT; dbSNP:rs104893700." id="VAR_058073" evidence="63">
<original>G</original>
<variation>E</variation>
<location>
<position position="670"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_058074" evidence="31">
<original>G</original>
<variation>R</variation>
<location>
<position position="670"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; dbSNP:rs773146939." id="VAR_078170" evidence="33">
<original>R</original>
<variation>H</variation>
<location>
<position position="680"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; dbSNP:rs121909261." id="VAR_003598" evidence="59">
<original>Q</original>
<variation>H</variation>
<location>
<position position="681"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; increased G-protein coupled receptor signaling pathway; does not affect cell membrane localization." id="VAR_078171" evidence="40">
<original>Q</original>
<variation>R</variation>
<location>
<position position="681"/>
</location>
</feature>
<feature type="sequence variant" description="In EIG8; patients present juvenile myoclonus epilepsy; dbSNP:rs753013993." id="VAR_060207" evidence="32">
<original>I</original>
<variation>V</variation>
<location>
<position position="686"/>
</location>
</feature>
<feature type="sequence variant" description="In NSHPT." id="VAR_065203" evidence="19">
<original>V</original>
<variation>M</variation>
<location>
<position position="689"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_065494" evidence="38">
<original>V</original>
<variation>M</variation>
<location>
<position position="697"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased protein level." id="VAR_078172" evidence="43">
<original>E</original>
<variation>V</variation>
<location>
<position position="707"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; increased G-protein coupled receptor signaling pathway; does not affect cell membrane localization; dbSNP:rs104893718." id="VAR_058075" evidence="27 40">
<original>L</original>
<variation>Q</variation>
<location>
<position position="727"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_058076" evidence="31">
<original>V</original>
<variation>F</variation>
<location>
<position position="728"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_058077" evidence="31">
<original>W</original>
<variation>R</variation>
<location>
<position position="742"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_078173" evidence="55">
<original>P</original>
<variation>R</variation>
<location>
<position position="748"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_078174" evidence="33">
<location>
<position position="761"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1." id="VAR_021019" evidence="21">
<original>E</original>
<variation>K</variation>
<location>
<position position="767"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; the mutation shifts the concentration-response curve to the left and increases maximal activity; dbSNP:rs104893699." id="VAR_058078" evidence="62">
<original>L</original>
<variation>R</variation>
<location>
<position position="773"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization." id="VAR_078175" evidence="43">
<original>G</original>
<variation>S</variation>
<location>
<position position="774"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; leftward shift in the concentration-response curve for the mutant receptor; cells cotransfected with both the wild-type and the mutant receptor show an EC(50) similar to the mutant; a gain-of-function mutation rendering the receptor more sensitive than normal to activation; dbSNP:rs104893701." id="VAR_058079" evidence="65">
<original>F</original>
<variation>C</variation>
<location>
<position position="788"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; induces a significant shift to the left relative to the wild-type protein in the MAPK response to increasing extracellular calcium concentrations; dbSNP:rs886041537 and dbSNP:rs104893711." id="VAR_058080" evidence="18">
<original>F</original>
<variation>L</variation>
<location>
<position position="788"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909258." id="VAR_003599" evidence="33 39 54 58">
<original>R</original>
<variation>W</variation>
<location>
<position position="795"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; increased G-protein coupled receptor signaling pathway." id="VAR_078176" evidence="33 41">
<original>N</original>
<variation>I</variation>
<location>
<position position="802"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs140022350." id="VAR_078177" evidence="41">
<original>N</original>
<variation>S</variation>
<location>
<position position="802"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; does not produce a significant activating effect; decreased cell surface receptor expression; dbSNP:rs104893693." id="VAR_003600" evidence="59 62">
<original>F</original>
<variation>S</variation>
<location>
<position position="806"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs1057518933." id="VAR_078178" evidence="61">
<original>V</original>
<variation>I</variation>
<location>
<position position="817"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; the concentration-response curve of the mutant receptor is left-shifted and its EC(50) is significantly lower than that of the wild-type; dbSNP:rs104893710." id="VAR_058081" evidence="14">
<original>S</original>
<variation>F</variation>
<location>
<position position="820"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1." id="VAR_078179" evidence="33">
<original>G</original>
<variation>S</variation>
<location>
<position position="830"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1." id="VAR_078180" evidence="33">
<original>F</original>
<variation>L</variation>
<location>
<position position="832"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1." id="VAR_078181" evidence="33">
<original>F</original>
<variation>S</variation>
<location>
<position position="832"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; increased G-protein coupled receptor signaling pathway." id="VAR_078182" evidence="42">
<original>I</original>
<variation>T</variation>
<location>
<position position="839"/>
</location>
</feature>
<feature type="sequence variant" description="In HYPOC1; also in HYPOC1 associated with clinical features of Bartter syndrome; shifts the concentration-response curve of calcium ions to the left; dbSNP:rs104893706." id="VAR_058082" evidence="15 16">
<original>A</original>
<variation>E</variation>
<location>
<position position="843"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs200777304." id="VAR_003601" evidence="59">
<original>C</original>
<variation>S</variation>
<location>
<position position="851"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated variant found in a patient with hypercalciuric hypercalcemia; mutant CASR has a right-shifted dose-response to extracellular calcium concentrations; activated by a higher calcium concentrations than the wild-type; dbSNP:rs104893704." id="VAR_058083" evidence="11">
<original>F</original>
<variation>L</variation>
<location>
<position position="881"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1." id="VAR_058084" evidence="31">
<original>R</original>
<variation>W</variation>
<location>
<position position="886"/>
</location>
</feature>
<feature type="sequence variant" description="In EIG8; dbSNP:rs121909269." id="VAR_060208" evidence="32">
<original>R</original>
<variation>Q</variation>
<location>
<position position="898"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4987051." id="VAR_020220">
<original>P</original>
<variation>T</variation>
<location>
<position position="951"/>
</location>
</feature>
<feature type="sequence variant" description="In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs200620134." id="VAR_078183" evidence="44">
<original>T</original>
<variation>M</variation>
<location>
<position position="972"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism associated with high serum level of calcium; is also a potential predisposing factor in disorders of bone and mineral metabolism; dbSNP:rs1801725." id="VAR_014450" evidence="8 12 19 20 26 30 31 32 34 55 67">
<original>A</original>
<variation>S</variation>
<location>
<position position="986"/>
</location>
</feature>
<feature type="sequence variant" description="In EIG8; patients present juvenile myoclonus epilepsy." id="VAR_060209" evidence="32">
<original>A</original>
<variation>G</variation>
<location>
<position position="988"/>
</location>
</feature>
<feature type="sequence variant" description="In EIG8; patients present juvenile myoclonus epilepsy; dbSNP:rs759027000." id="VAR_060210" evidence="32">
<original>A</original>
<variation>V</variation>
<location>
<position position="988"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism associated with low serum level of calcium; dbSNP:rs1042636." id="VAR_020221" evidence="14 19 20 21 31 32 52 55 67">
<original>R</original>
<variation>G</variation>
<location>
<position position="990"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs1801726." id="VAR_014451" evidence="19 20 31 34 55 67">
<original>E</original>
<variation>Q</variation>
<location>
<position position="1011"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes G-protein coupled receptor signaling pathway." evidence="49">
<original>R</original>
<variation>E</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes G-protein coupled receptor activity." evidence="49">
<original>N</original>
<variation>I</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes G-protein coupled receptor activity." evidence="49">
<original>T</original>
<variation>A</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="mutagenesis site" description="Nearly abolished G-protein coupled receptor activity." evidence="49">
<original>S</original>
<variation>A</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes G-protein coupled receptor activity." evidence="49">
<original>S</original>
<variation>A</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes G-protein coupled receptor activity." evidence="49">
<original>Y</original>
<variation>S</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ability to sense calcium or magnesium levels." evidence="48">
<original>E</original>
<variation>I</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes G-protein coupled receptor signaling pathway." evidence="49">
<original>S</original>
<variation>L</variation>
<location>
<position position="417"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased G-protein coupled receptor signaling pathway." evidence="49">
<original>W</original>
<variation>A</variation>
<location>
<position position="458"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ability of agonist AMG 416 to activate G-protein-coupled receptor activity." evidence="46">
<original>C</original>
<variation>S</variation>
<variation>Y</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAA09453." ref="3" evidence="73">
<original>I</original>
<variation>T</variation>
<location>
<position position="857"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAA09453." ref="3" evidence="73">
<original>A</original>
<variation>R</variation>
<location>
<position position="878"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA86503." ref="2" evidence="73">
<original>Q</original>
<variation>R</variation>
<location>
<position position="926"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="26"/>
<end position="28"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="31"/>
<end position="38"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="40"/>
<end position="44"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="60"/>
<end position="63"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="65"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="85"/>
<end position="90"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="93"/>
<end position="99"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="104"/>
<end position="114"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="116"/>
<end position="123"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="125"/>
<end position="128"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="138"/>
<end position="142"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="147"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="164"/>
<end position="168"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="172"/>
<end position="175"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="177"/>
<end position="179"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="183"/>
<end position="187"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="191"/>
<end position="203"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="208"/>
<end position="216"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="219"/>
<end position="232"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="237"/>
<end position="243"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="249"/>
<end position="261"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="266"/>
<end position="270"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="273"/>
<end position="285"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="292"/>
<end position="295"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="297"/>
<end position="300"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="303"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="308"/>
<end position="310"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="311"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="318"/>
<end position="322"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="330"/>
<end position="335"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="339"/>
<end position="341"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="343"/>
<end position="345"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="348"/>
<end position="356"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="358"/>
<end position="360"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="374"/>
<end position="378"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="384"/>
<end position="386"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="387"/>
<end position="389"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="401"/>
<end position="403"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="407"/>
<end position="409"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="416"/>
<end position="435"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="441"/>
<end position="444"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="445"/>
<end position="447"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="452"/>
<end position="454"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="457"/>
<end position="465"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="468"/>
<end position="470"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="476"/>
<end position="478"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="481"/>
<end position="485"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="489"/>
<end position="496"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="498"/>
<end position="500"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="502"/>
<end position="511"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="513"/>
<end position="515"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="519"/>
<end position="523"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="525"/>
<end position="527"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="531"/>
<end position="533"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="550"/>
<end position="554"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="556"/>
<end position="558"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="563"/>
<end position="567"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="576"/>
<end position="578"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="589"/>
<end position="591"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="595"/>
<end position="600"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5FBH"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5FBK"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5K5S"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5K5T"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P48442"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9QY96"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10023897"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10468915"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10487661"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10843194"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11161843"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11762699"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12050233"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12107202"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12241879"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12574188"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12915654"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14985373"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15531522"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15551332"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15572418"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15579740"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15879434"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16513638"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16598859"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16608894"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16740594"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17473068"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17555508"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17698911"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18756473"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19179454"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19789209"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20846291"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20861236"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21566075"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21643651"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22114145"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22789683"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23169696"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23966241"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25104082"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25292184"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25766501"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26290606"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26386835"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27386547"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27434672"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7673400"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7726161"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7759551"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7874174"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7916660"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8636323"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8675635"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8698326"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8702647"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8733126"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8813042"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8878438"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9253358"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9253359"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9298824"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9661634"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9920108"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="68" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17360426"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="27386547"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7759551"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8698326"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8813042"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000305"/>
<evidence key="74" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="27386547"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:1514"/>
</source>
</evidence>
<sequence length="1078" mass="120675" checksum="D60C57C6C743FC06" modified="2017-05-10" version="3" precursor="true">MAFYSCCWVLLALTWHTSAYGPDQRAQKKGDIILGGLFPIHFGVAAKDQDLKSRPESVECIRYNFRGFRWLQAMIFAIEEINSSPALLPNLTLGYRIFDTCNTVSKALEATLSFVAQNKIDSLNLDEFCNCSEHIPSTIAVVGATGSGVSTAVANLLGLFYIPQVSYASSSRLLSNKNQFKSFLRTIPNDEHQATAMADIIEYFRWNWVGTIAADDDYGRPGIEKFREEAEERDICIDFSELISQYSDEEEIQHVVEVIQNSTAKVIVVFSSGPDLEPLIKEIVRRNITGKIWLASEAWASSSLIAMPQYFHVVGGTIGFALKAGQIPGFREFLKKVHPRKSVHNGFAKEFWEETFNCHLQEGAKGPLPVDTFLRGHEESGDRFSNSSTAFRPLCTGDENISSVETPYIDYTHLRISYNVYLAVYSIAHALQDIYTCLPGRGLFTNGSCADIKKVEAWQVLKHLRHLNFTNNMGEQVTFDECGDLVGNYSIINWHLSPEDGSIVFKEVGYYNVYAKKGERLFINEEKILWSGFSREVPFSNCSRDCLAGTRKGIIEGEPTCCFECVECPDGEYSDETDASACNKCPDDFWSNENHTSCIAKEIEFLSWTEPFGIALTLFAVLGIFLTAFVLGVFIKFRNTPIVKATNRELSYLLLFSLLCCFSSSLFFIGEPQDWTCRLRQPAFGISFVLCISCILVKTNRVLLVFEAKIPTSFHRKWWGLNLQFLLVFLCTFMQIVICVIWLYTAPPSSYRNQELEDEIIFITCHEGSLMALGFLIGYTCLLAAICFFFAFKSRKLPENFNEAKFITFSMLIFFIVWISFIPAYASTYGKFVSAVEVIAILAASFGLLACIFFNKIYIILFKPSRNTIEEVRCSTAAHAFKVAARATLRRSNVSRKRSSSLGGSTGSTPSSSISSKSNSEDPFPQPERQKQQQPLALTQQEQQQQPLTLPQQQRSQQQPRCKQKVIFGSGTVTFSLSFDEPQKNAMAHRNSTHQNSLEAQKSSDTLTRHEPLLPLQCGETDLDLTVQETGLQGPVGGDQRPEVEDPEELSPALVVSSSQSFVISGGGSTVTENVVNS</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

